Page last updated: 2024-08-26

1,2-distearoylphosphatidylethanolamine and Melanoma

1,2-distearoylphosphatidylethanolamine has been researched along with Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hei, Y; Li, Q; Luo, Z; Pan, J; Teng, B; Wei, S; Xiong, C; Zeng, Z; Zhang, S1
Eggermont, AM; Koning, GA; Li, L; Lindner, LH; Schipper, D; ten Hagen, TL; van Rhoon, GC; Wijnberg, TM1

Other Studies

2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Melanoma

ArticleYear
Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; B7-H1 Antigen; Catalase; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Immunotherapy; Liposomes; Melanoma; Mice, Inbred C57BL; Phosphatidylethanolamines; Polyethylene Glycols; Tissue Distribution; Tumor Hypoxia; Tumor Microenvironment

2020
Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia.
    Journal of controlled release : official journal of the Controlled Release Society, 2010, Apr-19, Volume: 143, Issue:2

    Topics: Animals; Fluoresceins; Humans; Hyperthermia, Induced; Liposomes; Melanoma; Mice; Phosphatidylethanolamines; Polyethylene Glycols; Temperature

2010